Do you struggle with a CHRONIC COUGH?
Unable to find relief?

Research studies are enrolling now!

Those who qualify may receive*:

  • Payment up to $350, which varies by study
  • Study-related care at no cost from local doctors
  • Study medication at no cost

Ready to get started? Click Here.

If you have a nagging cough that has lasted for months or longer, you know the frustration and anxiety it can cause. Coughing can interrupt your sleep, make it difficult to concentrate, and raise concerns about the its underlying cause – not to mention the bother to others around you.

Common reasons for chronic coughing include asthma, postnasal drip, bronchitis, airborne irritants, and acid reflux. In fact, some people with reflux only experience cough without the traditional symptoms of heartburn.

While prescription and over-the-counter cough medicines help some people, many others continue to cough without relief. In fact, many individuals simply give up on finding a diagnosis and assume there’s nothing else they can do.

However, you have options. Right now, local research studies are evaluating a study medication for chronic cough that isn’t available from your regular doctor, and you may be eligible to participate.

Take the next step to see if you qualify for local research studies for people with Chronic Cough. But don’t delay — space is limited!

* In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. Reasonable payments will be made for participation and the length of the study may vary.

Ready to get started?

Click Here.

or

Call 833-213-1724

How does it work?

1

Tell us a little bit about yourself

2

Answer some questions about your health

3

We will connect you to available studies in your area

Just takes a few minutes

AcurianHealth

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.